Pathogenic variants in the SLC2A1 gene lead to reduced Glut1 protein expression or functional impairment, resulting in Glucose transporter type 1 deficiency syndrome (Glut1DS), which was first described by De Vivo et al. (1). The gene discussed is SLC2A1; the disease is encephalopathy due to GLUT1 deficiency.